Targeting α4β2 nicotinic acetylcholine receptors in central nervous system disorders: perspectives on positive allosteric modulation as a therapeutic approach.
about
Nicotinic ligands as multifunctional agents for the treatment of neuropsychiatric disordersAn Accessory Agonist Binding Site Promotes Activation of α4β2* Nicotinic Acetylcholine Receptors.A Novel α2/α4 Subtype-selective Positive Allosteric Modulator of Nicotinic Acetylcholine Receptors Acting from the C-tail of an α SubunitDifferential α4(+)/(-)β2 Agonist-binding Site Contributions to α4β2 Nicotinic Acetylcholine Receptor Function within and between Isoforms.Protein Kinase C Activation as a Potential Therapeutic Strategy in Alzheimer's Disease: Is there a Role for Embryonic Lethal Abnormal Vision-like Proteins?The development of novel polypharmacological agents targeting the multiple binding sites of nicotinic acetylcholine receptors.Orthosteric and allosteric potentiation of heteromeric neuronal nicotinic acetylcholine receptors.Unraveling amino acid residues critical for allosteric potentiation of (α4)3(β2)2-type nicotinic acetylcholine receptor responses.
P2860
Q30372351-6A9593A1-FB8F-4164-9988-EB95B17EF29CQ35662305-014EE54C-63C6-4194-A729-DDF60D06296BQ36323450-91A5090B-5F77-45C7-A0C3-937BF30CF2CBQ36518363-10E1156A-59EA-437E-BF4D-CD966B9CD7F4Q38784086-F5D20145-DC8F-493E-9A66-E30FFBE403D4Q38934855-F67B032F-6968-46A7-B222-6D5653D44298Q39136644-090DD1F0-C50D-456F-BC1B-9D9B4264EA8BQ48522591-AECE7F8A-6788-4D5E-93DE-AC2A06B81F48
P2860
Targeting α4β2 nicotinic acetylcholine receptors in central nervous system disorders: perspectives on positive allosteric modulation as a therapeutic approach.
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Targeting α4β2 nicotinic acety ...... ion as a therapeutic approach.
@ast
Targeting α4β2 nicotinic acety ...... ion as a therapeutic approach.
@en
Targeting α4β2 nicotinic acety ...... ion as a therapeutic approach.
@nl
type
label
Targeting α4β2 nicotinic acety ...... ion as a therapeutic approach.
@ast
Targeting α4β2 nicotinic acety ...... ion as a therapeutic approach.
@en
Targeting α4β2 nicotinic acety ...... ion as a therapeutic approach.
@nl
prefLabel
Targeting α4β2 nicotinic acety ...... ion as a therapeutic approach.
@ast
Targeting α4β2 nicotinic acety ...... ion as a therapeutic approach.
@en
Targeting α4β2 nicotinic acety ...... ion as a therapeutic approach.
@nl
P2093
P2860
P356
P1476
Targeting α4β2 nicotinic acety ...... ion as a therapeutic approach.
@en
P2093
Jesper Frank Bastlund
Morten Grunnet
Morten Grupe
P2860
P304
P356
10.1111/BCPT.12361
P577
2015-03-01T00:00:00Z